![]() |
市場調査レポート
商品コード
1625224
酸素療法機器市場の2030年までの予測:製品タイプ、携帯性、用途、エンドユーザー、地域別の世界分析Oxygen Therapy Equipment Market Forecasts to 2030 - Global Analysis By Product Type (Oxygen Source Equipment and Oxygen Delivery Devices), Portability (Portable Devices and Stationary Devices), Application, End User and By Geography |
||||||
カスタマイズ可能
|
酸素療法機器市場の2030年までの予測:製品タイプ、携帯性、用途、エンドユーザー、地域別の世界分析 |
出版日: 2025年01月01日
発行: Stratistics Market Research Consulting
ページ情報: 英文 200+ Pages
納期: 2~3営業日
|
Stratistics MRCによると、世界の酸素療法機器市場は2024年に48億米ドルを占め、予測期間中にCAGR 9.5%で成長し、2030年には82億米ドルに達すると予測されています。
酸素療法機器は、COPD、喘息、低酸素血症などの呼吸器疾患を持つ人々に補助酸素を供給するために設計された機器で構成されます。主なコンポーネントには、酸素濃縮器、ボンベ、鼻カニューレ、マスク、ポータブル酸素システムなどがあり、家庭用、病院用、外来用に調整されています。これらの機器は、呼吸効率を改善し、酸素飽和度を高め、重要な病状をサポートするために、最適な酸素供給を保証します。
CDCによると、米国では約1,600万人の成人が慢性閉塞性肺疾患(COPD)を患っています。
慢性呼吸器疾患の増加
COPD、喘息、肺線維症などの慢性呼吸器疾患の有病率の増加は、酸素療法機器市場の主要な促進要因です。大気汚染、喫煙、高齢化などの要因がこれらの症状の一因となっており、多くの患者に長期の酸素療法が必要となっています。この需要は、酸素療法の利点と生活の質を向上させる役割に対する意識の高まりによってさらに拡大しています。こうした呼吸器疾患が世界的に増加し続けていることから、酸素療法機器市場は大幅に拡大すると予想されます。
機器の高コスト
高度な酸素療法機器に関連する高コストが市場成長の大きな抑制要因となっています。こうしたコストは、特に低所得地域や包括的な保険が適用されない患者の多くにとって法外なものとなる可能性があります。経済的負担はヘルスケアプロバイダーの最新技術への投資能力にも影響し、効果的な呼吸ケアソリューションへのアクセスを制限する可能性があります。このような費用の障壁は治療の質の格差につながり、特に経済的余裕が重要な問題である新興諸国では市場開拓の妨げとなります。
在宅ヘルスケアサービスの拡大
在宅ヘルスケアサービスの拡大は、酸素療法機器市場にとって大きなチャンスです。特に高齢者や慢性疾患を抱える人々の間で在宅医療への嗜好が高まっており、携帯可能で使い勝手のよい酸素機器の需要が増加しています。この動向は、機器の携帯性と使いやすさを高める技術の進歩によって支えられています。自立性と快適性を維持するために在宅治療を選択する患者が増えるにつれて、在宅用酸素療法機器市場は大きく成長する見込みです。
複雑な規制要件
複雑な規制要件が酸素療法機器市場の脅威となっています。米国のFDAや欧州のCEマーキングなどの機関が定めた厳しい基準を遵守することは市場参入に不可欠であるが、メーカーにとっては困難でコストがかかります。これらの規制は安全性と有効性を保証するが、製品の発売を遅らせ、開発コストを増加させる可能性があります。
COVID-19の大流行は、患者の呼吸器合併症の増加により酸素療法機器の需要を大幅に押し上げました。この危機は、利用しやすい酸素供給の重要性を浮き彫りにし、病院と在宅介護の両方の環境での採用を加速させました。この需要の急増は市場内の急速な技術革新と拡大につながり、パンデミック後も持続的に成長する基盤を築いた。
予測期間中、酸素源機器分野が最大となる見込み
酸素源機器分野は、さまざまな環境において酸素療法を実施する上で不可欠な役割を果たすことから、予測期間中に最大の市場シェアを占めるとみられます。この分野には、病院での急性期治療と自宅での長期管理の両方に不可欠な濃縮器、ボンベ、液体システムが含まれます。同分野の優位性は、安定した酸素供給を必要とする呼吸器疾患の罹患率が上昇していることによる。
予測期間中、ポータブル機器分野のCAGRが最も高くなる見込み
予測期間中、ポータブル機器分野が最も高いCAGRを示すと予測されています。患者の可動性へのニーズの高まりと携帯型技術の進歩がこの成長の原動力となっています。ポータブル機器は利便性と柔軟性を提供するため、患者は必要な治療を受けながらライフスタイルを維持することができます。技術革新が携帯性と効率性を高め続けているため、この分野の急速な拡大が予想されます。
北米地域はヘルスケアインフラが発達しており、COPDや喘息などの呼吸器疾患の有病率が高いことから、予測期間中に最大の市場シェアを占めると予想されます。有利な償還政策と多額のヘルスケア支出がこの優位性をさらに支えています。また、大手メーカーの存在も北米の市場シェアを大きく押し上げています。
アジア太平洋地域は、呼吸ケアに対する意識の高まりと政府の支援策により、予測期間中に最も高い成長率を記録すると予測されています。中国やインドなどの国々では、高齢者人口の増加や医療インフラの改善がこの成長を後押ししています。先進医療機器への需要が高まるにつれ、アジア太平洋地域は世界市場において重要な成長地域として浮上しています。
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
According to Stratistics MRC, the Global Oxygen Therapy Equipment Market is accounted for $4.8 billion in 2024 and is expected to reach $8.2 billion by 2030 growing at a CAGR of 9.5% during the forecast period. Oxygen therapy equipment comprises devices designed to deliver supplemental oxygen to individuals with respiratory conditions such as COPD, asthma, or hypoxemia. Key components include oxygen concentrators, cylinders, nasal cannulas, masks, and portable oxygen systems, tailored for home, hospital, or ambulatory use. These devices ensure optimal oxygen delivery to improve breathing efficiency, enhance oxygen saturation levels, and support critical medical conditions.
According to the CDC, nearly 16 million adults in the United States have chronic obstructive pulmonary disease (COPD).
Rise in chronic respiratory conditions
The increasing prevalence of chronic respiratory conditions such as COPD, asthma, and pulmonary fibrosis is a major driver for the oxygen therapy equipment market. Factors like air pollution, smoking, and an aging population contribute to these conditions, necessitating long-term oxygen therapy for many patients. This demand is further amplified by the growing awareness of oxygen therapy's benefits and its role in improving quality of life. As these respiratory issues continue to rise globally, the market for oxygen therapy equipment is expected to expand significantly.
High costs of equipment
High costs associated with advanced oxygen therapy equipment are a significant restraint on market growth. These costs can be prohibitive for many patients, especially in low-income regions or for those without comprehensive insurance coverage. The financial burden also affects healthcare providers' ability to invest in the latest technologies, potentially limiting access to effective respiratory care solutions. This cost barrier can lead to disparities in treatment quality and hinder market expansion, particularly in developing countries where affordability is a critical concern.
Expansion of home healthcare services
The expansion of home healthcare services presents a significant opportunity for the oxygen therapy equipment market. With a growing preference for home-based care, particularly among the elderly and those with chronic conditions, demand for portable and user-friendly oxygen devices is increasing. This trend is supported by technological advancements that enhance device portability and ease of use. As more patients opt for home-based treatments to maintain independence and comfort, the market for home-use oxygen therapy equipment is poised for substantial growth.
Complex regulatory requirements
Complex regulatory requirements pose a threat to the oxygen therapy equipment market. Compliance with stringent standards set by bodies such as the FDA in the U.S. or CE marking in Europe is essential for market entry but can be challenging and costly for manufacturers. These regulations ensure safety and efficacy but can delay product launches and increase development costs.
The COVID-19 pandemic significantly boosted the demand for oxygen therapy equipment due to increased respiratory complications among patients. The crisis highlighted the importance of accessible oxygen supplies, accelerating adoption in both hospital and homecare settings. This surge in demand led to rapid innovations and expansions within the market, setting a foundation for sustained growth even post-pandemic.
The oxygen source equipment segment is expected to be the largest during the forecast period
The oxygen source equipment segment is expected to account for the largest market share during the forecast period due to its essential role in delivering oxygen therapy across various settings. This segment includes concentrators, cylinders, and liquid systems that are vital for both acute care in hospitals and long-term management at home. Its dominance is driven by the rising incidence of respiratory diseases requiring consistent oxygen supply.
The portable devices segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the portable devices segment is expected to witness the highest CAGR. The increasing need for mobility among patients and advancements in portable technology drive this growth. Portable devices offer convenience and flexibility, enabling patients to maintain their lifestyle while receiving necessary therapy. As innovations continue to enhance portability and efficiency, this segment's rapid expansion is anticipated.
The North America region is anticipated to account for the largest market share during the forecast period due to its advanced healthcare infrastructure and high prevalence of respiratory diseases like COPD and asthma. Favorable reimbursement policies and significant healthcare expenditure further support this dominance. The presence of leading manufacturers also contributes to North America's substantial market share.
The Asia Pacific region is anticipated to register the highest growth rate over the forecast period due to increasing awareness about respiratory care and supportive government initiatives. The rising geriatric population and improving healthcare infrastructure in countries like China and India bolster this growth. As demand for advanced medical devices increases, Asia Pacific emerges as a key growth region in the global market landscape.
Key players in the market
Some of the key players in Oxygen Therapy Equipment Market include Koninklijke Philips N.V., ResMed Inc., Invacare Corporation, Fisher & Paykel Healthcare Corporation Limited, AirSep Corporation, Dragerwerk AG & Co. KGaA, GE Healthcare, Medtronic PLC, Smiths Medical, Teleflex Incorporated, Drive DeVilbiss Healthcare, Nidek Medical Products Inc., O2 Concepts LLC, Inogen Inc., Chart Industries, Taiyo Nippon Sanso Corporation, Vyaire Medical Inc. and Precision Medical Inc.
In November 2023, Fisher & Paykel Healthcare Corporation Limited announced today it has released the Airvo 3 high flow system, which builds upon the market-leading Airvo 2, offering more advanced technology and a broader range of features for oxygen therapy delivery.
In June 2023, Philips has announced that the SimplyGo Mini portable oxygen concentrator conforms to FAA standards, making it available for on-board aircraft use, providing a new option for chronic respiratory patients who are on-the-go.
In February 2023, React Health subsidiary Ventec Systems has acquired Invacare's respiratory assets, including various oxygen therapy products. "With this acquisition, React Health is well positioned to continue to support the end-to-end care of patients with cardiology, sleep and respiratory illnesses, in partnership with physicians and providers of diagnostic and needed therapies," said Tom Pontzius, president of operations for React Health.